India to Kenya: Guaifenesin Export Trade Route
India has recorded 31 verified shipments of Guaifenesin exported to Kenya, representing a combined trade value of $363.9K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $11.7K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED, which accounts for 38% of total export value with 11 shipments worth $137.7K USD. On the buying side, ABACUS PHARMA (AFRICA) LTD is the largest importer in Kenya with $80.3K USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, ZYDUS LIFESCIENCES LIMITED , CADILA HEALTHCARE LIMITED — together control 83% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Guaifenesin corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $363.9K USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's guaifenesin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $11.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 30.1%, placing it at rank #20 among India's top guaifenesin export destinations globally.
On the import side, key buyers of Indian guaifenesin in Kenya include ABACUS PHARMA (AFRICA) LTD, ABACUS PHARMA AFRICA LTD, ABACUS PHARMA AFRICA LIMITED and 10 others. ABACUS PHARMA (AFRICA) LTD is the single largest importer with 6 shipments valued at $80.3K USD.
